Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04644432
What this trial is testing

Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney NeoplasmUrologic Neoplasms+1 more
Herlev and Gentofte Hospital 30
Not applicableStudy completedNCT04604158
What this trial is testing

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Who this might be right for
CancerCancer MetastaticNeoplasms+20 more
Gillian Gresham 38
Not applicableStudy completedNCT02465892
What this trial is testing

Pillars4Life Trial

Who this might be right for
Breast CancerLung CancerEsophageal Cancer+9 more
Duke University 284
Early research (Phase 1)Study completedNCT01472081
What this trial is testing

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Who this might be right for
Renal Cell CarcinomaClear-cell Metastatic Renal Cell Carcinoma
Bristol-Myers Squibb 194
Not applicableStudy completedNCT04154163
What this trial is testing

Appropriate Dosing to Optimise Personalised Cancer Treatments

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVOvarian Cancer+3 more
University of Dundee 18
Testing effectiveness (Phase 2)Looking for participantsNCT06682793
What this trial is testing

Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more
A2 Biotherapeutics Inc. 240
Not applicableStudy completedNCT01135849
What this trial is testing

B-Receptor Signaling in Cardiomyopathy

Who this might be right for
CarcinomasAmyloidosisAnal Cancer+35 more
Daniel Bernstein 99
Post-approval studies (Phase 4)Ended earlyNCT00930345
What this trial is testing

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 33
Not applicableStudy completedNCT00831857
What this trial is testing

VEGF Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University Medical Center Groningen 26
Testing effectiveness (Phase 2)Study completedNCT07568444
What this trial is testing

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Bladder CancerKidney Cancers+1 more
University of Southern California 120
Testing effectiveness (Phase 2)Study completedNCT03354884
What this trial is testing

CaBozantinib in cOllectiNg ductS Renal Cell cArcInoma

Who this might be right for
Collecting Duct Carcinoma (Kidney)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 23
Not applicableStudy completedNCT00836745
What this trial is testing

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Who this might be right for
Renal Cell Carcinoma
Pfizer 36
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07488572
What this trial is testing

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00609401
What this trial is testing

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic DiseaseRenal Cell Carcinoma
Italian Trial in Medical Oncology 90
Testing effectiveness (Phase 2)Ended earlyNCT01492192
What this trial is testing

RGD-PET-CT in Cancer Angiogenesis

Who this might be right for
Carcinoma, Renal Cell
Oxford University Hospitals NHS Trust 10
Not applicableTemporarily pausedNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT02917772
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 200
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableStudy completedNCT06214000
What this trial is testing

Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney

Who this might be right for
Prostate CancerKidney Cancer
University Hospital, Strasbourg, France 178
Not applicableStudy completedNCT03097601
What this trial is testing

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib

Who this might be right for
Metastatic Kidney Cancers
Centre Antoine Lacassagne 60
Next Page